Brief: Biocept Inc Estimates It Will Incur Charges Of About $0.6 Mln For Q1 2023 Severance Costs
Jan 6 (Reuters) - Biocept Inc BIOC.O :
* BIOCEPT INC - ESTIMATES THAT IT WILL INCUR CHARGES OF
ABOUT $0.6
MILLION FOR SEVERANCE AND OTHER EMPLOYEE TERMINATION-RELATED
COSTS IN Q1 OF 2023
* BIOCEPT INC - INTENDS TO CEASE COVID-19 TESTING AT END OF
JANUARY
* BIOCEPT INC - REDUCTION IN FORCE IS EXPECTED TO BE
COMPLETED
DURING Q1 OF 2023
Source: (shorturl.at/cS138)
Further company coverage: BIOC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Biocept
See all newsBrief: Biocept Says Trading Of Common Stock Will Be Suspended By Nasdaq At Opening Of Business On Oct 25
U.S. STOCKS ON THE MOVE-Overstock.com, Biocept, Birkenstock
Biocept slumps after filing for bankruptcy protection
Brief: Biocept CEO Antonino Morales Resigns
U.S. STOCKS ON THE MOVE-Albemarle, Novavax, WeWork